Signaling pathways involved in the regulation of TNFα-induced toll-like receptor 2 expression in human gingival fibroblasts

Cytokine

Volumn 57, Issue 3, 2012, Pages 406-416

  Davanian, Haleh ^a   Båge, Tove ^a   Lindberg, Johan ^b   Lundeberg, Joakim ^b   Q Concha, Hernan ^c   Sällberg Chen, Margaret ^a   Yucel Lindberg, Tülay ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Gingival fibroblasts; Microarray; Prostaglandins; TLR2; TNF

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; COMPLEMENTARY DNA; CYTOSOLIC PHOSPHOLIPASE A2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CHILD; CONTROLLED STUDY; DNA MICROARRAY; DNA SYNTHESIS; FIBROBLAST; FLOW CYTOMETRY; GINGIVAL FIBROBLAST; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYBRIDIZATION; MICROARRAY ANALYSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SCHOOL CHILD; SIGNAL TRANSDUCTION;

CHILD; CHILD, PRESCHOOL; FIBROBLASTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GINGIVA; HUMANS; JANUS KINASE 2; JNK MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PROSTAGLANDINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; TIME FACTORS; TOLL-LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR-ALPHA;

BACTERIA (MICROORGANISMS);

EID: 84856370445     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.12.008     Document Type: Article

References (52)

1. Pihlstrom B.L., Michalowicz B.S., Johnson N.W. Periodontal diseases. Lancet 2005, 366:1809-1820.
2. Akira S., Takeda K., Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001, 2:675-680.
3. Kumar H., Kawai T., Akira S. Toll-like receptors and innate immunity. Biochem Biophys Res Commun 2009, 388:621-625.
4. Sun Y., Shu R., Li C.L., Zhang M.Z. Gram-negative periodontal bacteria induce the activation of Toll-like receptors 2 and 4, and cytokine production in human periodontal ligament cells. J Periodontol 2010, 81:1488-1496.
5. O'Neill L.A. Therapeutic targeting of Toll-like receptors for inflammatory and infectious diseases. Curr Opin Pharmacol 2003, 3:396-403.
6. Carmody R.J., Chen Y.H. Nuclear factor-kappaB: activation and regulation during toll-like receptor signaling. Cell Mol Immunol 2007, 4:31-41.
7. Wang P., Meinhardt B., Andre R., Renshaw B.R., Kimber I., Rothwell N.J., et al. The interleukin-1-related cytokine IL-1F8 is expressed in glial cells, but fails to induce IL-1beta signalling responses. Cytokine 2005, 29:245-250.
8. Taylor P.C., Feldmann M. Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis. Nat Rev Rheumatol 2009, 5:578-582.
9. Passoja A., Puijola I., Knuuttila M., Niemela O., Karttunen R., Raunio T., et al. Serum levels of interleukin-10 and tumour necrosis factor-alpha in chronic periodontitis. J Clin Periodontol 2010, 37:881-887.
10. Sakai A., Ohshima M., Sugano N., Otsuka K., Ito K. Profiling the cytokines in gingival crevicular fluid using a cytokine antibody array. J Periodontol 2006, 77:856-864.
11. Assuma R., Oates T., Cochran D., Amar S., Graves D.T. IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J Immunol 1998, 160:403-409.
12. Gartlehner G., Hansen R.A., Jonas B.L., Thieda P., Lohr K.N. The comparative efficacy and safety of biologics for the treatment of rheumatoid arthritis: a systematic review and metaanalysis. J Rheumatol 2006, 33:2398-2408.
13. Chen K., Huang J., Gong W., Iribarren P., Dunlop N.M., Wang J.M., et al. Toll-like receptors in inflammation, infection and cancer. Int Immunopharmacol 2007, 7:1271-1285.
14. Urbonaviciute V., Furnrohr B.G., Meister S., Munoz L., Heyder P., De Marchis F., et al. Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J Exp Med 2008, 205:7-3018.
15. Mullick A.E., Tobias P.S., Curtiss L.K. Modulation of atherosclerosis in mice by Toll-like receptor 2. J Clin Invest 2005, 115:3149-3156.
16. Westerterp M., Berbee J.F., Pires N.M., van Mierlo G.J., Kleemann R., Romijn J.A., et al. Apolipoprotein C-I is crucially involved in lipopolysaccharide-induced atherosclerosis development in apolipoprotein E-knockout mice. Circulation 2007, 116:2173-2181.
17. Sun Y., Guo Q.M., Liu D.L., Zhang M.Z., Shu R., et al. In vivo expression of Toll-like receptor 2, Toll-like receptor 4, CSF2 and LY64 in Chinese chronic periodontitis patients. Oral Dis 2010, 16:343-350.
18. Lappin D.F., Sherrabeh S., Erridge C. Stimulants of Toll-like receptors 2 and 4 are elevated in saliva of periodontitis patients compared with healthy subjects. J Clin Periodontol 2011, 38:318-325.
19. Wang P.L., Azuma Y., Shinohara M., Ohura K. Toll-like receptor 4-mediated signal pathway induced by Porphyromonas gingivalis lipopolysaccharide in human gingival fibroblasts. Biochem Biophys Res Commun 2000, 273:1161-1167.
20. Tabeta K., Yamazaki K., Akashi S., Miyake K., Kumada H., Umemoto T., et al. Toll-like receptors confer responsiveness to lipopolysaccharide from Porphyromonas gingivalis in human gingival fibroblasts. Infect Immun 2000, 68:3731-3735.
21. Gutierrez-Venegas G., Arrieta S.C., Villeda-Navarro Jr M., Mendez-Mejia J.A. Histamine promotes the expression of receptors TLR2 and TLR4 and amplifies sensitivity to lipopolysaccharide and lipoteichoic acid treatment in human gingival fibroblasts. Cell Biol Int 2011, 35:1009-1017.
22. Mori Y., Yoshimura A., Ukai T., Lien E., Espevik T., Hara Y. Immunohistochemical localization of Toll-like receptors 2 and 4 in gingival tissue from patients with periodontitis. Oral Microbiol Immunol 2003, 18:54-58.
23. Båge T., Lindberg J., Lundeberg J., Modeer T., Yucel-Lindberg T. Signal pathways JNK and NF-kappaB, identified by global gene expression profiling, are involved in regulation of TNFalpha-induced mPGES-1 and COX-2 expression in gingival fibroblasts. BMC Genomics 2010, 11:241.
24. Glonek G.F., Solomon P.J. Factorial and time course designs for cDNA microarray experiments. Biostatistics 2004, 5:89-111.
25. Lindberg J., af Klint E., Ulfgren A.K., Stark A., Andersson T., Nilsson P., et al. Variability in synovial inflammation in rheumatoid arthritis investigated by microarray technology. Arthritis Res Ther 2006, 8:R47.
26. KTH core facility homepage, 2011. <>. http://www.biotech.kth.se/molbio/microarray/.
27. Maglott D., Ostell J., Pruitt K.D., Tatusova T. Entrez Gene: gene-centered information at NCBI. Nucleic Acids Res 2007, 35:26-31.
28. R: A language and environment for statistical computing, 2011. <>. http://www.R-project.org.
29. Gentleman R.C., Carey V.J., Bates D.M., Bolstad B., Dettling M., Dudoit S., et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004, 5:R80.
30. Yang Y.H., Dudoit S., Luu P., Lin D.M., Peng V., Ngai J., et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 2002, 30:e15.
31. Barrett T., Troup D.B., Wilhite S.E., Ledoux P., Rudnev D., Evangelista C., et al. NCBI GEO: mining tens of millions of expression profiles - database and tools update. Nucleic Acids Res 2007, 35:760-765.
32. Smyth G.K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004, 3. [Article3].
33. Reiner A., Yekutieli D., Benjamini Y. Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics 2003, 19:368-375.
34. Web-based gene set analysis toolkit, 2011. <>. http://bioinfo.vanderbilt.edu/webgestalt.
35. Rhee S.H., Jones B.W., Toshchakov V., Vogel S.N., Fenton M.J. Toll-like receptors 2 and 4 activate STAT1 serine phosphorylation by distinct mechanisms in macrophages. J Biol Chem 2003, 278:22506-22512.
36. Leoncini G., Bruzzese D., Signorello M.G. Activation of p38 MAPKinase/cPLA2 pathway in homocysteine-treated platelets. J Thromb Haemost 2006, 4:209-216.
37. Guan S.M., Fu S.M., He J.J., Zhang M. Prevotella intermedia induces prostaglandin E2 via multiple signaling pathways. J Dent Res 2011, 90:121-127.
38. Winder A.A., Wohlford-Lenane C., Scheetz T.E., Nardy B.N., Manzel L.J., Look D.C., et al. Differential effects of cytokines and corticosteroids on toll-like receptor 2 expression and activity in human airway epithelia. Respir Res 2009, 10:96.
39. Satta N., Kruithof E.K., Reber G., de Moerloose P. Induction of TLR2 expression by inflammatory stimuli is required for endothelial cell responses to lipopeptides. Mol Immunol 2008, 46:145-157.
40. Syed M.M., Phulwani N.K., Kielian T. Tumor necrosis factor-alpha (TNF-alpha) regulates Toll-like receptor 2 (TLR2) expression in microglia. J Neurochem 2007, 103:1461-1471.
41. Vardar-Sengul S., Arora S., Baylas H., Mercola D. Expression profile of human gingival fibroblasts induced by interleukin-1beta reveals central role of nuclear factor-kappa B in stabilizing human gingival fibroblasts during inflammation. J Periodontol 2009, 80:833-849.
42. Salmeron A., Ahmad T.B., Carlile G.W., Pappin D., Narsimhan R.P., Ley S.C. Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase. EMBO J 1996, 15:817-826.
43. Guma M., Kashiwakura J., Crain B., Kawakami Y., Beutler B., Firestein G.S., et al. JNK1 controls mast cell degranulation and IL-1{beta} production in inflammatory arthritis. Proc Natl Acad Sci USA 2010, 107:22122-22127.
44. Musikacharoen T., Matsuguchi T., Kikuchi T., Yoshikai Y. NF-kappa B and STAT5 play important roles in the regulation of mouse Toll-like receptor 2 gene expression. J Immunol 2001, 166:4516-4524.
45. Wang T., Lafuse W.P., Zwilling B.S. NFkappaB and Sp1 elements are necessary for maximal transcription of toll-like receptor 2 induced by Mycobacterium avium. J Immunol 2001, 167:6924-6932.
46. Phulwani N.K., Esen N., Syed M.M., Kielian T. TLR2 expression in astrocytes is induced by TNF-alpha- and NF-kappa B-dependent pathways. J Immunol 2008, 181:3841-3849.
47. Han J. MyD88 beyond Toll. Nat Immunol 2006, 7:370-371.
48. Baetz A., Frey M., Heeg K., Dalpke A.H. Suppressor of cytokine signaling (SOCS) proteins indirectly regulate toll-like receptor signaling in innate immune cells. J Biol Chem 2004, 279:54708-54715.
49. Powell W.S. 15-Deoxy-delta12,14-PGJ2: endogenous PPAR gamma ligand or minor eicosanoid degradation product?. J Clin Invest 2003, 112:828-830.
50. Scher J.U., Pillinger M.H. 15d-PGJ2: the anti-inflammatory prostaglandin?. Clin Immunol 2005, 114:100-109.
51. Zhang F., Liu F., Yan M., Ji H., Hu L., Li X., et al. Peroxisome proliferator-activated receptor-gamma agonists suppress iNOS expression induced by LPS in rat primary Schwann cells. J Neuroimmunol 2010, 218:36-47.
52. Yoon H.J., Jeon S.B., Kim I.H., Park E.J. Regulation of TLR2 expression by prostaglandins in brain glia. J Immunol 2008, 180:8400-8409.